Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 39 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Theravance Biopharma, Inc. | 9,511,150 | reported | 07 Aug 2024 | tx 3+2,498,924 |
| PFSWEB INC | 1,750,189 | reported | 29 Dec 2022 | tx 13+2,818,745−2,633,000 |
| SYNOVUS FINANCIAL CORP | 1,293,259 | reported | 10 Jun 2024 | tx 21+292,882−400,000 |
| Stagwell Inc | 141,923 | reported | 02 Jan 2026 | tx 24+3,145,996 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Stagwell Inc | 4,090 | 4.89 USD | |
| 01 Oct 2025 | GRANT_AWARD | Stagwell Inc | 3,552 | 5.63 USD | |
| 01 Jul 2025 | GRANT_AWARD | Stagwell Inc | 4,444 | 4.50 USD | |
| 12 Jun 2025 | GRANT_AWARD | Stagwell Inc | 30,000 | 0.00 USD | |
| 04 Jun 2025 | PURCHASE | Stagwell Inc | 425,757 | 4.27 USD | |
| 05 Jun 2025 | PURCHASE | Stagwell Inc | 240,000 | 4.43 USD | |
| 09 May 2025 | PURCHASE | Stagwell Inc | 200,903 | 4.76 USD | |
| 01 Apr 2025 | GRANT_AWARD | Stagwell Inc | 3,305 | 6.05 USD | |
| 02 Jan 2025 | GRANT_AWARD | Stagwell Inc | 3,040 | 6.58 USD | |
| 01 Oct 2024 | GRANT_AWARD | Stagwell Inc | 2,849 | 7.02 USD | |
| 07 Aug 2024 | PURCHASE | Theravance Biopharma, Inc. | 999,800 | 7.80 USD | |
| 01 Jul 2024 | GRANT_AWARD | Stagwell Inc | 2,933 | 6.82 USD | |
| 12 Jun 2024 | GRANT_AWARD | Stagwell Inc | 22,762 | 0.00 USD | |
| 10 Jun 2024 | SALE | SYNOVUS FINANCIAL CORP | 172,889 | 25.20 USD | |
| 05 Jun 2024 | SALE | SYNOVUS FINANCIAL CORP | 6,803 | 25.22 USD | |
| 06 Jun 2024 | SALE | SYNOVUS FINANCIAL CORP | 325 | 25.24 USD | |
| 07 Jun 2024 | SALE | SYNOVUS FINANCIAL CORP | 20 | 25.20 USD | |
| 03 Jun 2024 | SALE | SYNOVUS FINANCIAL CORP | 13,685 | 25.23 USD | |
| 04 Jun 2024 | SALE | SYNOVUS FINANCIAL CORP | 6,278 | 25.23 USD | |
| 31 May 2024 | SALE | SYNOVUS FINANCIAL CORP | 200,000 | 25.07 USD | |
| 01 May 2024 | PURCHASE | Theravance Biopharma, Inc. | 999,800 | 8.75 USD | |
| 01 May 2024 | PURCHASE | Theravance Biopharma, Inc. | 499,324 | 8.75 USD | |
| 20 Oct 2023 | PURCHASE | SYNOVUS FINANCIAL CORP | 560 | 21.35 USD | |
| 13 Oct 2023 | PURCHASE | SYNOVUS FINANCIAL CORP | 4,279 | 21.50 USD | |
| 12 Oct 2023 | PURCHASE | SYNOVUS FINANCIAL CORP | 235 | 21.50 USD |